Industry Data Updates

Explore the latest industry insights through clear, data-driven visualisations, and discover the current status of clinical studies worldwide.

A white magnifying glass icon is inspecting a graph on a dark blue circular background

Clinical trials approaching key delivery milestones

Explore 4,540 industry-led, multi-country Phase 1–3 trials spanning 112 countries, including 1,372 with primary completion reported within the next 12 months. These visuals reveal patterns across geography, therapeutic area, phase, recruitment status and sponsors—highlighting areas for closer review while recognising that reported dates can change and do not confirm delays.

Relevant trial landscape

4,540 trials

Details: Global, industry-led,

Phase 1-3 interventional trials

 

Global reach

112 countries

Details: Recorded trial locations span 112 countries

Primary completion in 12 months

1,372 trials

Details: Based on the latest reported primary completion date

Open to recruitment

2,548 trials

Details: Recruiting, not yet recruiting or enrolling by invitation

Here will be the visuals

Keeping studies on track starts with keeping participants engaged

The data shows that 1,098 trials had passed their latest reported primary completion date, including 147 still open to recruitment. The records cannot explain why, but participant retention could be one of the pressures affecting delivery.

Trial Flow helps sponsors build participant-first retention strategies that keep people informed, supported and engaged throughout the trial journey.

Talk to us today about improving retention, reducing avoidable drop-off and helping your study stay on track.

Talk to us about your trial
Trial Flow demo screens